These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22856614)

  • 1. ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
    Franchini M; Favaloro EJ; Targher G; Lippi G
    Crit Rev Clin Lab Sci; 2012; 49(4):137-49. PubMed ID: 22856614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
    Jenkins PV; O'Donnell JS
    Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.
    O'Donnell J; Laffan MA
    Transfus Med; 2001 Aug; 11(4):343-51. PubMed ID: 11532189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women.
    Guimarães DA; dos Santos MS; Gomes KB; van der Bom JG; Rios DR; Cardoso J; Franco RM; Teixeira Gda S; Dusse LM; Carvalho Md; Fernandes AP
    Menopause; 2012 Mar; 19(3):339-45. PubMed ID: 22089178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia.
    Cohen W; Castelli C; Alessi MC; Aillaud MF; Bouvet S; Saut N; Brunet D; Barthet MC; Tregouet DA; Lavigne G; Morange PE
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2021-8. PubMed ID: 22628432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
    Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
    Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
    Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
    Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood group and von Willebrand factor: biological implications.
    Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
    Clin Chem Lab Med; 2014 Sep; 52(9):1273-6. PubMed ID: 24945431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
    Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
    Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
    Ward SE; O'Sullivan JM; O'Donnell JS
    Blood; 2020 Dec; 136(25):2864-2874. PubMed ID: 32785650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ABO blood group on von Willebrand response to exercise.
    Ribeiro JL; Salton GD; Bandinelli E; Oliveira AR; Roisenberg I
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):454-8. PubMed ID: 18160595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor.
    O'Donghaile D; Jenkins PV; McGrath RT; Preston L; Field SP; Ward SE; O'Sullivan JM; O'Donnell JS
    Sci Rep; 2020 Oct; 10(1):18366. PubMed ID: 33110150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
    Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
    Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
    Lison S; Dietrich W; Spannagl M
    Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
    O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
    Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.